Biomea Fusion

Attending the EASD 2024 Meeting in Madrid? If so, then please join us at the INNODIA "Shine a Light on T1D" Symposium on September 9, 2024 during the 2024 EASD Conference in Madrid, Spain! Dr Juan Pablo Frias, CMO and Head of Diabetes of Biomea Fusion will be just one of the many speakers who will provide information focused on therapies for type 1 diabetes. For attendees, this is a unique chance to learn about recent developments in the field and the therapies that are currently in development. Don’t miss this invaluable opportunity to engage with leading experts and contribute to the future of diabetes care. IMPORTANT: To attend the INNODIA "Shine a Light on T1D" Symposium, you must register by July 17, 2024. Register Here: https://bit.ly/3WnlcDo The Symposium is open to all, regardless of EASD Congress registration but you must be present to attend.

Congratulations, American Diabetes Association, 2024 Banting Medal Recipient Rory R. Holman. Emeritus Professor of Diabetic Medicine at the University of Oxford. Read his U.K. Prospective Diabetes Study 16 here: https://bit.ly/3L6ZvB4

Biomea Fusion had the pleasure of attending the American Diabetes Association's Women’s Interprofessional Networking Reception. This inspiring event brought together female clinicians, scientists, educators, and other health professionals involved in diabetes care and research. It served as a vital platform to amplify the voice and presence of women in the diabetes field, recognize their significant contributions, and facilitate networking among professionals with shared goals. The evening was filled with insightful presentations, meaningful discussions, and numerous opportunities for attendees to connect and share their insights. We left feeling motivated and empowered, and we're excited to support the ongoing efforts of women in the diabetes community. Thank you to everyone who made this event a success! #ADA2024 #WomenInDiabetes #Networking #Innovation

We're thrilled to kick off the first day of ADA2024 at booth #833 for Biomea Fusion! The energy is already buzzing, and we’re excited to engage with attendees about our latest innovations in diabetes research and treatment. A huge thank you to everyone planning to stop by today. If you haven’t had the chance yet, swing by booth #833 to learn more about how Biomea Fusion is shaping the future of diabetes care. See you soon! 👋 #ADA2024 #DiabetesResearch #Innovation

Learn about Biomea Fusion and how the protein menin is involved in diabetes and is a critical target in the development of new treatments. https://lnkd.in/gtg73Ani

What exactly is covalency? Check out our video to find out what a covalent molecule is and don't forget to explore our small covalent molecules hematological malignancies, solid tumors and hashtag #T2D at https://biomeafusion.com #ADA2024 #MeninProtein #BMEA #BiomeaFusion

We at Biomea Fusion are thrilled to support and participate in the ADA 2024 conference! This prestigious event is a cornerstone for advancing diabetes research and treatment, bringing together experts, innovators, and advocates to share groundbreaking insights and solutions. At Biomea Fusion, our mission aligns with ADA’s commitment to improving the lives of those affected by diabetes. We’re eager to contribute to the dialogue on innovative therapies and cutting-edge research that will shape the future of diabetes care. Join us in championing the fight against diabetes and be a part of this inspiring journey toward a healthier future. Let’s innovate, collaborate, and make a lasting impact together! #ADA2024 #Biomeafusion #DiabetesResearch #HealthcareInnovation #Collaboration #FutureOfHealth

Celebrating Freedom and Equality on Juneteenth Today, as we commemorate Juneteenth, we at Biomea Fusion reflect on the profound significance of this day—marking the emancipation of the last remaining enslaved African Americans in the Confederacy. Juneteenth is not only a day of celebration but also a reminder of the journey toward equality and justice for all. At Biomea Fusion, we are committed to fostering an inclusive workplace where every voice is heard and valued. We believe that diversity drives innovation and that equality is essential to our success as a company and as a society. In honor of Juneteenth, we encourage our team to participate in community events and educational programs that promote understanding and advancement in the fight for civil rights. Let us all pledge to continue the work needed to build a more equitable world. Happy Juneteenth! #Juneteenth #Equality #Inclusion #BiomeaFusion

The American Diabetes Association has updated its standards of care to include new treatments and strategies. Notable updates include new screening practices, the use of emerging diabetes technologies, and recommendations on obesity management in diabetic patients.

Steve Morris, Chief Development Officer and Alex Cacovean, VP-Clinical Development are excited to announce the presentation of our poster, "Covalent-103: A Phase 1, Open-Label, Dose Escalation, and Expansion Study of BMF-500, an Oral Covalent FLT3 Inhibitor, in Adults with Acute Leukemia (AL)" at #ASCO2024!  #TeamFusion #leukemia #bmf-500 https://bit.ly/4aYsjq2